Articles published by Collegium Pharmaceutical, Inc.
Collegium to Participate in Upcoming Investor Conferences
November 12, 2024
Via GlobeNewswire
Tickers
COLL
Collegium Reports Record Third Quarter 2024 Financial Results
November 07, 2024
Via GlobeNewswire
Tickers
COLL
Collegium Appoints Vikram Karnani as Chief Executive Officer
November 07, 2024
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Collegium Completes Acquisition of Ironshore Therapeutics
September 04, 2024
Via GlobeNewswire
Tickers
COLL
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
August 30, 2024
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Collegium Reports Second Quarter 2024 Financial Results
August 08, 2024
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
June 13, 2024
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
February 08, 2024
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Collegium Announces $25 Million Accelerated Share Repurchase Program
November 09, 2023
Via GlobeNewswire
Tickers
COLL
Collegium to Participate in Upcoming Investor Conferences
November 08, 2023
Via GlobeNewswire
Tickers
COLL
Collegium Reports Third Quarter 2023 Financial Results
November 07, 2023
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Via GlobeNewswire
Tickers
COLL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.